≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Precocious puberty

DOID EFO Endpoint Browser PheWeb

E4_PREPUB

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — E30.1
  • Hospital discharge: ICD-9 — 2591
  • Cause of death: ICD-10 — E30.1
  • Cause of death: ICD-9 — 2591

2 out of 7 registries used, show all original rules.

196

4. Check minimum number of events

None

196

5. Include endpoints

None

196

6. Filter based on genotype QC (FinnGen only)

196

Control definitions (FinnGen only)

Control exclude
E4_ENDOGLAND

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
E30
Name in latin
Pubertas praecox

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 3614 2856 755
Only index persons 3025 2327 698
Unadjusted period prevalence (%)
Whole population 0.07 0.08 0.02
Only index persons 0.07 0.09 0.03
Median age at first event (years)
Whole population 9.48 8.97 11.38
Only index persons 9.57 9.01 11.43

-FinnGen-

Key figures

All Female Male
Number of individuals 196 164 32
Unadjusted period prevalence (%) 0.05 0.06 0.01
Median age at first event (years) 9.50 8.95 12.28

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
172
Matched controls
1720
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E30.1
ICD-10 Finland
Precocious puberty
+∞
208.3
155
*
L02AE02
ATC
leuprorelin; implant, parenteral
86.0
36.8
40
6
E22.80
ICD-10 Finland
Central precocious puberty
377.9
32.0
31
*
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
24.5
30.2
43
23
2591A
ICD-9 Finland
Other endocrine disorders, Precocious sexual development and puberty, not elsewhere classified
+∞
20.2
19
*
Z51.80
ICD-10 Finland
Manipulation of puberty development with hormone therapy
+∞
19.1
18
*
E27.0
ICD-10 Finland
Other adrenocortical overactivity
64.1
10.8
12
*
L02AE04
ATC
triptorelin; parenteral
+∞
8.4
8
*
E34.45
ICD-10 Finland
Abnormal growth increase
83.5
7.5
8
*
E30.8
ICD-10 Finland
Other disorders of puberty
+∞
7.3
7
*
P05.1
ICD-10 Finland
Small for gestational age
18.9
6.3
9
5
E30.9
ICD-10 Finland
Disorder of puberty, unspecified
+∞
6.3
6
*
H01AC01
ATC
somatropin; parenteral
+∞
6.3
6
*

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023323) Follitropin [Units/volume] in Serum or Plasma
41
90
5.50
18.51
3.3
1.7
iu/l
7.0
9.4
0.43
32
62
(3009214) Lutropin [Units/volume] in Serum or Plasma
44
109
4.92
17.23
3.4
1.6
u/l
4.6
6.9
2.11
32
78
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
13
8
17.28
8.68
2.0
1.4
nmol/l
5.6
3.9
—
13
8
(3042936) Bacteria identified in Isolate by Culture
29
126
2.53
4.53
2.4
2.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
20
73
2.94
4.33
7.8
5.1
%
0.2
0.1
—
6
18
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
81
540
1.85
4.16
12.0
7.8
mmol/l
1.2
1.2
0.68
73
481
(3015377) Calcium [Moles/volume] in Serum or Plasma
55
323
1.98
4.14
3.2
2.1
mmol/l
2.4
2.4
0.05
50
290
(3025159) Blasts/100 leukocytes in Blood
19
71
2.86
3.95
7.9
5.3
%
0.0
0.0
—
6
16
(3017181) Myelocytes/100 leukocytes in Blood
20
77
2.78
3.95
7.8
4.9
%
0.3
0.6
—
6
20
(3018418) pH of Serum or Plasma
45
254
2.00
3.76
6.0
3.0
ph
7.4
7.4
1.13
12
43
(3021901) Oxygen saturation in Capillary blood
8
14
5.91
3.37
2.1
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
79
551
1.73
3.33
3.7
2.6
nmol/l
75.1
66.8
1.52
74
506
(3019550) Sodium [Moles/volume] in Serum or Plasma
159
1364
1.88
3.01
11.9
7.9
mmol/l
139.3
139.4
0.28
152
1305
(3026250) Tacrolimus [Mass/volume] in Blood
6
9
6.83
2.89
54.2
40.0
ug/l
6.5
6.7
—
6
9
(3023103) Potassium [Moles/volume] in Serum or Plasma
158
1359
1.84
2.88
11.7
7.9
mmol/l
3.9
3.9
0.11
151
1293
(3026782) Osmolality of Urine
44
270
1.81
2.83
3.7
2.4
mosm/kgh2o
610.2
611.2
0.01
37
223
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
18
79
2.41
2.77
1.7
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
14
55
2.66
2.68
2.6
1.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
8
20
4.12
2.59
1.0
1.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
70
501
1.62
2.55
6.0
4.5
umol/l
8.4
9.9
1.28
65
451
(3023368) Bacteria identified in Blood by Culture
35
207
1.84
2.52
4.5
4.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
11
39
2.93
2.52
1.7
1.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
18
83
2.29
2.50
10.9
6.8
ng/l
62.8
48.8
0.77
18
78
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
29
163
1.91
2.44
10.6
4.5
mmol/l
0.6
1.1
0.38
18
116
(3014765) Yersinia sp identified in Stool by Organism specific culture
11
40
2.85
2.41
1.7
1.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
29
164
1.90
2.39
10.8
4.5
kpa
5.1
5.1
0.05
29
155
(3035637) Corticotropin [Mass/volume] in Plasma
8
22
3.74
2.39
1.5
1.7
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
33
195
1.83
2.38
12.5
7.3
mmol/l
24.8
24.9
0.01
33
195
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
48
318
1.67
2.34
4.6
2.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
11
41
2.78
2.32
1.7
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
59
414
1.61
2.30
8.2
6.8
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
61
433
1.59
2.26
5.7
3.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
31
184
1.81
2.21
14.0
9.4
mmol/l
1.2
1.2
0.16
31
178
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
30
3.09
2.17
1.3
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
30
3.09
2.17
1.3
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
14
4.38
2.16
2.0
7.9
—
—
—
0
0
(3022313) Gas panel - Capillary blood
24
132
1.93
2.15
12.0
5.2
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
17
82
2.18
2.14
6.6
9.5
mmol/l
106.1
106.2
0.02
17
82
(3021589) Normoblasts [#/volume] in Blood
97
775
1.50
2.07
9.6
7.8
e9/l
0.1
0.0
0.50
79
607
(3032080) INR in Blood by Coagulation assay
43
287
1.64
2.03
3.0
3.7
inr
1.0
1.0
0.07
16
99
(3036481) Cortisol [Moles/volume] in Serum or Plasma
25
143
1.86
2.00
3.2
2.2
nmol/l
416.9
404.8
0.11
25
133
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
5
11
4.63
1.95
1.0
1.1
pmol/l
23.0
166.6
—
5
11
(3001604) Monocytes [#/volume] in Blood
100
811
1.48
1.94
8.1
6.5
e9/l
0.6
0.5
0.95
88
696
(3006315) Basophils [#/volume] in Blood
100
811
1.48
1.94
8.1
6.5
e9/l
0.0
0.0
0.19
89
695
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
14
65
2.24
1.93
2.2
1.6
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
104
851
1.47
1.93
8.0
4.6
u/l
93.0
85.8
0.42
96
791
(3048689) Calprotectin [Mass/mass] in Stool
46
317
1.59
1.91
3.1
2.8
ug/g
105.5
64.0
0.67
33
239
(4306422)
8
28
2.93
1.88
1.1
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
26
154
1.79
1.87
5.7
4.4
umol/l
6.3
7.3
0.12
20
116
(3025941) Bacteria identified in Stool by Culture
16
80
2.09
1.86
1.4
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
5
12
4.24
1.83
1.6
1.8
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
105
868
1.45
1.80
7.9
6.3
e9/l
2.3
2.1
1.35
96
766
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
17
89
2.00
1.76
1.5
1.7
u/ml
189.2
183.9
—
10
46
(3017143) Hepatitis C virus Ab [Presence] in Serum
47
332
1.55
1.75
1.9
1.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
52
376
1.52
1.74
4.6
2.8
e6/l
0.3
0.3
0.18
41
268
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
24
2.99
1.74
1.1
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
124
1063
1.45
1.72
8.0
5.7
ml/min/173m2
111.5
109.9
0.29
95
733
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
25
151
1.75
1.70
1.6
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
19
105
1.90
1.70
1.2
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
55
405
1.50
1.69
4.7
2.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
14
69
2.11
1.69
2.2
1.6
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
100
829
1.42
1.64
9.5
7.1
e9/l
0.2
0.2
0.04
93
722
(3033658) Prothrombin time (PT) actual/Normal
44
311
1.53
1.63
6.3
5.0
%
94.5
91.9
0.29
44
301
(3013707) Erythrocyte sedimentation rate by Westergren method
115
979
1.42
1.62
5.1
3.6
mm/h
7.5
7.4
0.03
110
909
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
17
92
1.93
1.62
1.5
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
16
85
1.96
1.60
1.4
1.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
108
911
1.41
1.59
10.3
7.6
e9/l
4.1
3.8
0.48
97
771
(3000850) Epithelial cells [#/volume] in Urine
41
287
1.54
1.59
3.8
2.4
e6/l
6.4
10.1
0.95
34
237
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
12
57
2.18
1.58
1.8
1.6
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
16
86
1.94
1.55
1.3
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
70
552
1.42
1.49
8.8
6.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
126
1102
1.40
1.44
3.3
2.3
mmol/l
5.5
5.4
0.28
119
993
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
15
81
1.92
1.44
1.6
1.4
ug/l
2.4
3.1
0.64
15
76
(1616796) Gas panel - Central venous blood
6
22
2.78
1.44
3.0
2.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
22
2.78
1.44
1.0
1.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
152
1376
1.47
1.42
5.1
4.2
mu/l
2.4
1.8
0.77
144
1296
(4035726)
11
53
2.14
1.41
1.5
1.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
51
383
1.45
1.41
4.6
2.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
54
410
1.44
1.41
5.3
2.8
e6/l
9.0
77.0
2.35
43
295
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
15
83
1.87
1.35
2.5
5.7
g/l
4.3
3.1
0.98
15
77
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
167
1547
1.54
1.32
12.5
8.6
mg/l
19.3
21.6
0.40
123
1104
(3027315) Oxygen [Partial pressure] in Blood
6
24
2.55
1.31
3.0
2.3
kpa
9.8
9.6
—
6
24
(3013290) Carbon dioxide [Partial pressure] in Blood
6
24
2.55
1.31
3.0
2.3
kpa
5.5
4.7
—
6
24
(3028626) Oxygen [Partial pressure] in Capillary blood
22
139
1.66
1.30
10.8
4.0
kpa
10.3
9.8
0.78
22
131
(21494755) Public health laboratory ask at order entry panel
10
187
0.51
1.27
1.3
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
162
1497
1.47
1.24
10.0
6.7
u/l
27.6
23.5
0.83
156
1434
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
136
1220
1.37
1.24
4.8
3.7
pmol/l
14.2
14.3
0.26
128
1106
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
26
174
1.57
1.23
1.4
1.3
iu/ml
27.7
148.3
—
8
60
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
11
57
1.99
1.19
2.0
1.9
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
20
127
1.64
1.17
10.5
5.6
%
1.6
1.4
0.65
20
114
(3018133) Calcium [Moles/volume] in Urine
5
20
2.54
1.16
2.6
5.1
mmol/l
2.1
1.9
—
5
20
(36660697) Celiac disease serology panel - Serum
35
254
1.46
1.15
1.1
1.2
—
—
—
0
0
(3013512) EKG study
26
177
1.54
1.15
2.1
2.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
25
169
1.55
1.14
9.2
8.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
70
575
1.34
1.12
1.5
1.5
g/l
1.8
1.8
0.15
37
313
(3018095) Leukocytes [#/volume] in Urine
65
528
1.35
1.12
6.6
3.2
e6/l
49.2
73.6
0.25
44
316
(3021879) Hepatitis B virus core Ab [Presence] in Serum
29
206
1.48
1.06
1.8
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
22
2.30
1.04
1.2
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
17
107
1.64
1.03
1.1
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
17
107
1.64
1.03
1.2
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
7
35
2.04
1.01
3.3
1.8
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
17
108
1.63
1.00
3.4
2.7
pmol/l
5.3
4.9
1.28
17
96
(3002256) Pathology report gross observation
17
108
1.63
1.00
1.2
1.1
—
—
—
0
0
(4268621)
5
23
2.20
0.98
2.6
2.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
6
27
2.26
0.94
1.7
20.7
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
17
112
1.57
0.88
1.4
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
25
180
1.45
0.87
2.2
2.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
29
217
1.39
0.83
4.8
2.4
e6/l
3.4
3.9
0.14
15
102
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
32
1.90
0.82
3.5
3.7
e9/l
2.7
3.4
—
6
32
(3000494) Fungus identified in Specimen by Culture
16
106
1.55
0.82
1.4
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
75
646
1.26
0.81
1.5
1.7
u/ml
3.9
3.1
0.10
15
137
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
33
1.84
0.79
3.5
3.8
%
50.7
52.4
—
6
33
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
5
100
0.49
0.79
1.2
1.2
u/ml
1.0
2.1
—
5
49
(3037467) Urinalysis macro (dipstick) panel - Urine
117
1063
1.25
0.78
5.6
3.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
35
275
1.33
0.75
2.2
2.8
mg/l
0.8
1.4
0.77
24
180
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
24
2.11
0.75
1.4
1.0
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
7
38
1.87
0.74
1.7
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
27
204
1.38
0.74
1.5
1.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
54
452
1.27
0.73
2.4
2.3
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
7
39
1.82
0.73
1.9
3.2
nmol/l
0.8
0.5
—
7
33
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
25
2.03
0.73
2.0
1.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
25
2.03
0.73
1.2
1.2
—
—
—
0
0
(3000492) Spirometry study
9
142
0.62
0.73
1.0
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
40
1.78
0.72
2.1
2.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
48
397
1.28
0.72
3.0
3.0
estimate
0.0
0.0
0.50
20
160
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
76
664
1.24
0.71
5.6
4.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
26
1.95
0.71
1.4
1.0
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
7
41
1.73
0.70
2.3
1.7
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
18
128
1.45
0.68
1.2
1.3
u/ml
208.5
496.8
0.68
18
120
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
30
234
1.33
0.68
1.7
2.1
ng/l
25.7
11.3
0.43
11
58
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
44
1.61
0.66
1.0
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
23
173
1.37
0.65
1.5
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
23
173
1.37
0.65
2.1
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
10
152
0.64
0.64
1.2
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
22
165
1.38
0.64
1.6
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
51
432
1.24
0.63
3.1
2.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
8
51
1.59
0.61
6.1
6.0
—
1.1
—
0
15
(3022145) Colonoscopy Study observation
11
72
1.56
0.60
2.1
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
113
0.61
0.60
1.0
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
73
647
1.20
0.58
2.2
2.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
5
86
0.57
0.57
2.0
2.1
—
21.2
—
0
5
(3010726) Horse dander IgE Ab [Units/volume] in Serum
5
87
0.56
0.57
1.0
1.1
—
8.3
—
0
22
(3003888) Timothy IgE Ab [Units/volume] in Serum
5
88
0.56
0.57
1.2
1.2
u/ml
13.1
7.4
—
5
65
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
36
1.69
0.57
1.0
1.0
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
14
99
1.45
0.56
1.5
1.8
g/l
1.2
1.2
0.08
14
89
(40768804) Tissue Pathology biopsy report
47
400
1.23
0.56
2.1
1.6
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
18
134
1.38
0.55
1.6
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
18
134
1.38
0.55
1.6
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
168
1615
1.28
0.55
11.1
7.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
83
748
1.19
0.55
3.6
3.0
estimate
0.0
0.0
0.00
21
161
(3035350) Ketones [Presence] in Urine by Test strip
82
739
1.19
0.54
3.7
2.9
estimate
0.0
0.0
0.00
19
155
(40760892) CBC W Ordered Manual Differential panel - Blood
43
364
1.23
0.53
5.3
3.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
63
1.45
0.53
1.1
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
14
190
0.72
0.52
1.2
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
10
67
1.52
0.50
1.2
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
33
273
1.25
0.50
3.0
2.4
u/l
5683.9
4898.2
0.08
17
114
(3000330) Specific gravity of Urine by Test strip
7
45
1.58
0.49
2.7
1.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
18
138
1.34
0.47
1.7
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
11
77
1.45
0.46
2.4
2.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
5
85
0.58
0.46
1.2
1.2
u/ml
0.9
0.7
—
5
53
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
7
50
1.41
0.45
1.4
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
27
222
1.25
0.44
4.2
2.4
e6/l
0.5
1.0
0.78
14
108
(3021601) Nitrite [Presence] in Urine by Test strip
81
740
1.16
0.44
5.5
4.1
estimate
0.0
0.0
0.00
20
163
(3008898) HLA-B27 [Presence]
6
95
0.62
0.43
1.0
1.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
41
354
1.20
0.43
1.7
1.4
pmol/l
92.4
96.4
0.27
23
191
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
27
223
1.24
0.42
3.6
1.9
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
183
1789
1.35
0.41
18.4
12.8
e9/l
278.4
267.1
1.39
175
1732
(3045414) Leukocytes [Presence] in Urine
8
59
1.37
0.41
2.0
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
41
356
1.19
0.40
1.5
1.5
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
5
34
1.48
0.40
1.2
1.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
5
34
1.48
0.40
1.2
3.3
mmol/l
4.4
3.5
—
5
34
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
5
34
1.48
0.40
1.4
3.3
e6/l
200.4
230.1
—
5
29
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
5
34
1.48
0.40
2.0
26.8
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
24
197
1.25
0.40
1.1
1.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
12
89
1.37
0.39
1.8
1.4
—
—
—
0
0
(3015736) pH of Urine
66
600
1.15
0.37
3.2
2.7
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
5
79
0.62
0.36
1.0
1.2
—
26.3
—
0
5
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
47
418
1.16
0.36
3.1
2.6
mg/l
2.6
2.4
0.22
38
359
(40761536) Microorganisms panel - Urine sediment
18
145
1.27
0.35
2.4
3.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
183
1794
1.30
0.35
18.4
12.7
e12/l
4.5
4.5
0.17
174
1735
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
160
1645
0.85
0.33
4.8
4.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
183
1796
1.29
0.32
18.4
12.7
e9/l
7.3
6.9
1.68
175
1732
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
20
166
1.23
0.31
1.9
2.3
ng/l
218.0
542.8
—
6
66
(3028707) Methadone [Presence] in Urine by Screen method
15
120
1.27
0.31
1.3
1.9
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
12
152
0.78
0.30
1.5
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
10
76
1.33
0.28
3.2
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
60
552
1.13
0.28
3.0
2.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
56
515
1.12
0.27
2.0
2.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
47
428
1.13
0.26
1.7
1.9
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
21
243
0.85
0.25
1.3
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
39
353
1.13
0.24
3.6
2.8
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
5
37
1.36
0.23
1.2
3.2
mg/l
751.8
337.0
—
5
37
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
38
1.32
0.23
3.6
2.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
38
1.32
0.23
3.4
2.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
20
172
1.18
0.23
1.6
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
20
172
1.18
0.23
1.6
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
20
172
1.18
0.23
1.6
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
33
366
0.88
0.23
1.5
1.5
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
5
40
1.26
0.22
1.8
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
20
173
1.17
0.22
1.9
2.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
20
173
1.17
0.22
1.6
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
84
798
1.09
0.21
2.3
2.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(4094501)
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.1
—
151.2
—
0
12
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
51
1.18
0.19
1.7
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
22
195
1.14
0.18
1.4
1.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
7
61
1.15
0.17
6.4
4.4
—
—
—
0
0
(4010399)
7
63
1.12
0.17
1.6
1.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
94
904
1.08
0.17
4.7
2.9
u/l
29.2
25.4
0.54
89
868
(3019225) pH of Specimen
5
70
0.71
0.17
14.4
5.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
63
661
0.93
0.15
2.3
2.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
23
208
1.12
0.14
1.7
1.5
titre
368.0
667.4
—
5
35
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
15
170
0.87
0.14
1.7
1.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
9
109
0.82
0.13
1.4
1.5
nmol/l
765.2
991.9
—
9
86
(3019150) Specific gravity of Urine by Refractometry
38
357
1.08
0.12
2.4
2.6
kg/l
1.0
1.0
—
8
49
(1761868) Lipid panel - Serum or Plasma
36
381
0.93
0.10
2.4
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
22
203
1.09
0.10
1.1
1.2
iu/ml
11.3
13.7
—
7
43
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
47
1.07
0.09
1.2
1.8
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
54
1.11
0.09
1.8
1.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
69
711
0.95
0.08
2.7
2.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
7
84
0.83
0.07
2.0
2.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
62
602
1.04
0.07
1.8
1.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
9
85
1.06
0.07
1.6
2.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
23
244
0.93
0.07
1.4
1.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
23
243
0.94
0.06
1.4
1.8
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
21
198
1.07
0.05
1.7
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
23
242
0.94
0.05
1.4
1.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
23
242
0.94
0.05
1.4
1.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
79
805
0.97
0.05
2.5
2.3
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
11
101
1.09
0.04
3.0
2.7
umol/l
3.2
5.2
—
6
80
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
45
462
0.97
0.04
1.7
1.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
94
927
1.03
0.04
5.4
2.8
ug/l
48.3
49.9
0.06
83
865
(3009542) Hematocrit [Volume Fraction] of Blood
163
1622
1.03
0.02
14.3
10.2
%
38.7
39.9
1.21
140
1415
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
10
107
0.93
0.02
1.4
4.1
ng/l
653.2
604.0
—
5
83
(3003694) ABO and Rh group [Type] in Blood
67
664
1.01
0.00
1.9
1.9
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
22
221
0.99
0.00
1.4
1.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
64
636
1.01
0.00
2.3
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
10
105
0.95
0.00
2.2
2.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
19
188
1.01
0.00
1.1
1.2
u/ml
1.1
6.6
—
8
71
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4211845)
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
5.6
—
0
7
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.1
—
5.1
—
0
7
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4146454)
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.0
—
824.7
—
0
9
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
79.7
—
0
5
(3009871) Measles virus Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
8
79
1.01
0.00
2.3
1.3
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.4
—
357.0
—
0
5
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
5.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
86
0.93
0.00
1.1
1.2
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
82
0.97
0.00
1.1
1.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
60
1.00
0.00
1.2
1.3
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
33.6
—
0.5
—
0
5
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
0.7
—
0
6
(3006442) Creatine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
0.1
—
0
6
(21491868) Cryoglobulin [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
5
0.00
0.00
0.0
5.6
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint E4_PREPUB and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have E4_PREPUB.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

↥

Index endpoint: E4_PREPUB – Precocious puberty

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data